Literature DB >> 19482769

Pitfalls, problems, and progress in bronchopulmonary dysplasia.

Anita Bhandari1, Vineet Bhandari.   

Abstract

Bronchopulmonary dysplasia is a chronic lung disease associated with premature birth and characterized by early lung injury. In this review we discuss some pitfalls, problems, and progress in this condition over the last decade, focusing mainly on the last 5 years, limited to studies in human neonates. Changes in the definition, pathogenesis, genetic susceptibility, and recent biomarkers associated with bronchopulmonary dysplasia will be discussed. Progress in current management strategies, along with novel approaches/therapies, will be critically appraised. Finally, recent data on long-term pulmonary and neurodevelopmental outcomes of infants with bronchopulmonary dysplasia will be summarized.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19482769     DOI： 10.1542/peds.2008-1962

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  85 in total

1.  Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung.

Authors:  Vedang A Londhe; Isaac K Sundar; Benjamin Lopez; Tiffany M Maisonet; Yang Yu; Zubair H Aghai; Irfan Rahman
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants.

Authors:  Joanna Floros; Douglas Londono; Derek Gordon; Patricia Silveyra; Susan L Diangelo; Rose M Viscardi; George S Worthen; Jeffrey Shenberger; Guirong Wang; Zhenwu Lin; Neal J Thomas
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

3.  A genome-wide association study (GWAS) for bronchopulmonary dysplasia.

Authors:  Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich
Journal:  Pediatrics       Date:  2013-07-29       Impact factor: 7.124

Review 4.  Particle transport and deposition: basic physics of particle kinetics.

Authors:  Akira Tsuda; Frank S Henry; James P Butler
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

5.  Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.

Authors:  Jawahar Jagarapu; Jelte Kelchtermans; Min Rong; Shaoyi Chen; Dorothy Hehre; Stefanie Hummler; Mohd Hafeez Faridi; Vineet Gupta; Shu Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

Review 6.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

7.  Bridging the gaps: getting evidence into practice.

Authors:  William McGuire; Peter W Fowlie
Journal:  CMAJ       Date:  2009-08-10       Impact factor: 8.262

8.  Continuous Positive Airway Pressure versus Mechanical Ventilation on the First Day of Life in Very Low-Birth-Weight Infants.

Authors:  Dustin D Flannery; Elizabeth O'Donnell; Mike Kornhauser; Kevin Dysart; Jay Greenspan; Zubair H Aghai
Journal:  Am J Perinatol       Date:  2016-04-08       Impact factor: 1.862

Review 9.  An update on pharmacologic approaches to bronchopulmonary dysplasia.

Authors:  Sailaja Ghanta; Kristen Tropea Leeman; Helen Christou
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 10.  Progress in understanding the genetics of bronchopulmonary dysplasia.

Authors:  Gary M Shaw; Hugh M O'Brodovich
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.